There’s a lot of stigma around Mounjaro and a recent study found that people think weight loss that’s brought on by weight ...

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

Weight loss jabs could impact your contraception. Here’s why - ANALYSIS: Simon Cork on the surprising side effect of weight ...

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

A 28-year-old man who started using the injectable medication on Saturday (7 June) has opened up on his experience so far ...

Weight loss jabs like mounjaro could be as transformative as statins, the NHS’s top doctor has said. Cholesterol-busting statins are one of the most commonly prescribed drugs in the UK, with around ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

Agents such as semaglutide, liraglutide, and tirzepatide are now integral to treatment algorithms for type 2 diabetes, obesity, and related comorbidities. With their success, however, has come ...